Friday, May 11, 2018
Wavemaker Three-Sixty Targets Healthcare Investments
Pasadena-based Wavemaker Three-Sixty Health, a new, venture capital fund led by John Nackel and Jay Goss, said this week that it has launched a new fund focused on seed stage and Series A healthcare investments. The new fund is worth $25M. According to Wavemaker Three-Sixty Health, the new fund is a joint venture between Wavemaker and Three-Sixty Advisory Group, LLC, a healthcare consultancy and business accelerator. Nackel is former head of E&Y's global healthcare practice, former head of E&Y's venture fund, and CEO of UnitedHealth Group's Ingenix Consulting, now Optum, and
Goss has been an executive at RxVantage, Mogreet, Numedeon, Kumba Health, ExecuSurv.